Drug Design, Development and Therapy
Volume 14, 2020 - Issue
Original Research
The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution
, , , 
, &
Yi Luo1 Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of Chinahttps://orcid.org/0000-0002-4206-6273
https://orcid.org/0000-0002-4206-6273, & Li Min1 Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-5035-1672
https://orcid.org/0000-0002-5035-1672